Variant report

Variant	nsv1064332
Chromosome Location	chr19:43241500-43370644
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:1865)
CpG islands
(count:977)
Chromatin interactive
region (count:7)
LncRNA
region (count:20)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:1865 , 50 per page) page: 1 2 3 4 5 6 7 ... 38

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ATF3	chr19:43355048-43355947	A549	lung:	n/a	n/a
2	ATF3	chr19:43335349-43336094	A549	lung:	n/a	n/a
3	ATF3	chr19:43335307-43336092	A549	lung:	n/a	n/a
4	ATF3	chr19:43355412-43355889	A549	lung:	n/a	n/a
5	ATF3	chr19:43336349-43336838	A549	lung:	n/a	n/a
6	ATF3	chr19:43336336-43336928	A549	lung:	n/a	n/a
7	BATF	chr19:43246213-43246502	GM12878	blood:	n/a	n/a
8	BATF	chr19:43271446-43271728	GM12878	blood:	n/a	n/a
9	BATF	chr19:43361555-43361754	GM12878	blood:	n/a	n/a
10	BATF	chr19:43302238-43302533	GM12878	blood:	n/a	chr19:43302344-43302355
11	BCL3	chr19:43335292-43335990	A549	lung:	n/a	chr19:43335602-43335611 chr19:43335603-43335612
12	BCL3	chr19:43297507-43298116	A549	lung:	n/a	n/a
13	BCL3	chr19:43335242-43336126	A549	lung:	n/a	chr19:43335602-43335611 chr19:43335603-43335612
14	BCL3	chr19:43323095-43323355	GM12878	blood:	n/a	n/a
15	BCL3	chr19:43336159-43337656	A549	lung:	n/a	chr19:43336227-43336234
16	BCL3	chr19:43354910-43356058	A549	lung:	n/a	n/a
17	BCL3	chr19:43336972-43337663	A549	lung:	n/a	n/a
18	BCL3	chr19:43336292-43336877	A549	lung:	n/a	n/a
19	BCL3	chr19:43354946-43356043	A549	lung:	n/a	n/a
20	BHLHE40	chr19:43355572-43355890	A549	lung:	n/a	n/a
21	BRCA1	chr19:43297623-43297950	Hela-S3	cervix:	n/a	n/a
22	BRCA1	chr19:43355288-43355847	Hela-S3	cervix:	n/a	n/a
23	BRCA1	chr19:43265411-43265577	Hela-S3	cervix:	n/a	n/a
24	CEBPB	chr19:43337171-43337381	A549	lung:	n/a	n/a
25	CEBPB	chr19:43329196-43329407	HepG2	liver:	n/a	chr19:43329341-43329352
26	CEBPB	chr19:43329190-43329511	A549	lung:	n/a	chr19:43329341-43329352
27	CEBPB	chr19:43326599-43326799	A549	lung:	n/a	n/a
28	CEBPB	chr19:43345870-43346046	IMR90	lung:	n/a	n/a
29	CEBPB	chr19:43329328-43329348	IMR90	lung:	n/a	n/a
30	CEBPB	chr19:43329315-43329373	K562	blood:	n/a	chr19:43329341-43329352
31	CEBPB	chr19:43265127-43265827	Hela-S3	cervix:	n/a	n/a
32	CEBPB	chr19:43335425-43335832	MCF-7	breast:	n/a	n/a
33	CEBPB	chr19:43324277-43324368	A549	lung:	n/a	n/a
34	CEBPB	chr19:43336500-43336748	A549	lung:	n/a	n/a
35	CEBPB	chr19:43335339-43335868	A549	lung:	n/a	n/a
36	CEBPB	chr19:43355051-43355897	A549	lung:	n/a	n/a
37	CEBPB	chr19:43328156-43328419	IMR90	lung:	n/a	chr19:43328257-43328268
38	CEBPB	chr19:43355095-43355943	Hela-S3	cervix:	n/a	n/a
39	CEBPB	chr19:43335434-43335820	Hela-S3	cervix:	n/a	n/a
40	CEBPB	chr19:43354986-43356104	A549	lung:	n/a	n/a
41	CEBPB	chr19:43328208-43328426	Hela-S3	cervix:	n/a	chr19:43328257-43328268
42	CEBPB	chr19:43336488-43336863	Hela-S3	cervix:	n/a	n/a
43	CEBPB	chr19:43355113-43355853	A549	lung:	n/a	n/a
44	CEBPB	chr19:43324137-43324522	IMR90	lung:	n/a	n/a
45	CEBPB	chr19:43265183-43265848	IMR90	lung:	n/a	n/a
46	CEBPB	chr19:43297755-43297993	A549	lung:	n/a	n/a
47	CEBPB	chr19:43328228-43328417	HepG2	liver:	n/a	chr19:43328257-43328268
48	CEBPB	chr19:43339173-43339354	Hela-S3	cervix:	n/a	n/a
49	CEBPB	chr19:43335389-43335855	A549	lung:	n/a	n/a
50	CEBPB	chr19:43337158-43337425	Hela-S3	cervix:	n/a	n/a

(count:977 , 50 per page) page: 1 2 3 4 5 6 7 ... 20

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr19:43360229-43360279	HAEpiC	amniotic membrane:	n/a
2	chr19:43360229-43360279	HAEpiC	amniotic membrane:	n/a
3	chr19:43244680-43244730	HAEpiC	amniotic membrane:	n/a
4	chr19:43245860-43245910	ProgFib	skin:	n/a
5	chr19:43269832-43269882	ProgFib	skin:	n/a
6	chr19:43269832-43269882	GM19239	blood:	n/a
7	chr19:43271004-43271054	HEEpiC	esophagus:	n/a
8	chr19:43269877-43269927	HCPEpiC	choroid plexus:	n/a
9	chr19:43244635-43244685	HEEpiC	esophagus:	n/a
10	chr19:43360755-43360805	K562	blood:	n/a
11	chr19:43244635-43244685	BE2_C	brain:	n/a
12	chr19:43271112-43271162	H1-hESC	embryonic stem cell:	embryo
13	chr19:43360755-43360805	SK-N-SH	brain:	n/a
14	chr19:43257346-43257396	SKMC	muscle:	n/a
15	chr19:43244635-43244685	NB4	blood:	n/a
16	chr19:43271112-43271162	NT2-D1	testis:	n/a
17	chr19:43244635-43244685	PANC-1	pancreas:	n/a
18	chr19:43271004-43271054	A549	lung:	n/a
19	chr19:43359870-43359920	HIPEpiC	eye:	n/a
20	chr19:43361218-43361268	IMR90	lung:	fetal
21	chr19:43257346-43257396	AG10803	skin:	n/a
22	chr19:43244635-43244685	HUVEC	blood vessel:	n/a
23	chr19:43360229-43360279	HCT-116	colon:	n/a
24	chr19:43269877-43269927	HRPEpiC	eye:	n/a
25	chr19:43244635-43244685	HRCEpiC	kidney:	n/a
26	chr19:43355659-43355709	U87	brain:	n/a
27	chr19:43244635-43244685	Hela-S3	cervix:	n/a
28	chr19:43265778-43265828	NH-A	brain:	n/a
29	chr19:43269832-43269882	Caco-2	colon:	n/a
30	chr19:43271004-43271054	NH-A	brain:	n/a
31	chr19:43359870-43359920	AG09309	skin:	n/a
32	chr19:43244680-43244730	NHBE	bronchial:	n/a
33	chr19:43265778-43265828	GM19239	blood:	n/a
34	chr19:43245921-43245971	IMR90	lung:	fetal
35	chr19:43271112-43271162	LNCaP	prostate:	n/a
36	chr19:43271112-43271162	MCF-7	breast:	n/a
37	chr19:43244635-43244685	IMR90	lung:	fetal
38	chr19:43265778-43265828	U87	brain:	n/a
39	chr19:43271112-43271162	NH-A	brain:	n/a
40	chr19:43269832-43269882	Jurkat	blood:	n/a
41	chr19:43361218-43361268	HRPEpiC	eye:	n/a
42	chr19:43245921-43245971	H1-hESC	embryonic stem cell:	embryo
43	chr19:43269832-43269882	H1-hESC	embryonic stem cell:	embryo
44	chr19:43271004-43271054	HCF	heart:	n/a
45	chr19:43245921-43245971	BJ	skin:	n/a
46	chr19:43245860-43245910	Jurkat	blood:	n/a
47	chr19:43361218-43361268	AG09319	gingival:	n/a
48	chr19:43271112-43271162	HPAEpiC	pulmonary alveolar:	n/a
49	chr19:43355659-43355709	SK-N-MC	brain:	n/a
50	chr19:43245921-43245971	MCF-7	breast:	n/a

(count:7 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr19:43297087..43297875-chr19:43423005..43423976,2	MCF-7	breast:
2	chr19:43197633..43198568-chr19:43280847..43281639,2	K562	blood:
3	chr19:43139154..43139986-chr19:43246322..43246897,2	MCF-7	breast:
4	chr19:43197619..43198590-chr19:43246174..43246898,3	MCF-7	breast:
5	chr19:43197647..43198196-chr19:43280850..43281744,2	MCF-7	breast:
6	chr19:43197626..43198528-chr19:43245881..43246809,2	MCF-7	breast:
7	chr19:43265768..43266290-chr19:43769932..43770473,2	MCF-7	breast:

(count:20 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-PSG1-1	chr19:43343447-43343530	NONHSAT066571
2	lnc-PSG3-1	chr19:43258485-43260276	NONHSAT066566
3	lnc-PSG1-1	chr19:43343520-43343530	NONHSAT146988
4	lnc-PSG3-1	chr19:43256843-43257528	NONHSAT066566
5	lnc-PSG1-1	chr19:43359708-43359870	NONHSAT146988
6	lnc-PSG6-3	chr19:43370618-43371302	NONHSAT066572
7	lnc-PSG8-1	chr19:43289879-43290117	NONHSAT066567
8	lnc-PSG1-1	chr19:43358101-43358466	NONHSAT146988
9	lnc-PSG1-1	chr19:43358101-43358466	NONHSAT066571
10	lnc-PSG1-1	chr19:43343708-43343916	NONHSAT146988
11	lnc-PSG1-1	chr19:43348511-43348765	NONHSAT066571
12	lnc-PSG1-1	chr19:43341149-43341602	NONHSAT066570
13	lnc-PSG1-1	chr19:43349168-43349446	NONHSAT146988
14	lnc-PSG1-1	chr19:43348511-43348765	NONHSAT146988
15	lnc-PSG1-1	chr19:43349168-43349446	NONHSAT066571
16	lnc-PSG8-1	chr19:43290505-43290747	NONHSAT066567
17	lnc-PSG1-1	chr19:43341149-43341534	NONHSAT066571
18	lnc-PSG1-1	chr19:43343708-43343916	NONHSAT066571
19	lnc-PSG8-1	chr19:43285358-43285449	NONHSAT066567
20	lnc-PSG1-1	chr19:43359708-43359870	NONHSAT066571

No data

Variant related genes	Relation type
PSG8	TF binding region
ENSG00000225877	TF binding region
CEACAMP6	TF binding region
PSG3	TF binding region
PSG10P	TF binding region
PSG8	CpG island
ENSG00000225877	CpG island
CEACAMP6	CpG island
PSG3	CpG island
PSG10P	CpG island
ENSG00000170848	chromatin interactions

Extended variants
information (count: 6925 )
Associated
traits (count: 65 )

Variant overlapped rSNPs/rCNVs (count:6925 , 50 per page) page: 1 2 3 4 5 6 7 ... 139

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs191815779	chr19:43241506-43241507	Enhancers Weak transcription Active TSS	n/a	n/a	Overlapped CNVs	n/a
2	rs117010997	chr19:43241519-43241520	Enhancers Weak transcription Active TSS	n/a	n/a	Overlapped CNVs	n/a
3	rs543314301	chr19:43241532-43241533	Enhancers Weak transcription Active TSS	n/a	n/a	Overlapped CNVs	n/a
4	rs148516374	chr19:43241534-43241535	Enhancers Weak transcription Active TSS	n/a	n/a	Overlapped CNVs	n/a
5	rs552633373	chr19:43241538-43241539	Enhancers Weak transcription Active TSS	n/a	n/a	Overlapped CNVs	n/a
6	rs183985991	chr19:43241552-43241553	Enhancers Weak transcription Active TSS	n/a	n/a	Overlapped CNVs	n/a
7	rs186875548	chr19:43241553-43241554	Enhancers Weak transcription Active TSS	n/a	n/a	Overlapped CNVs	n/a
8	rs60594018	chr19:43241568-43241569	Enhancers Weak transcription Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
9	rs370966498	chr19:43241569-43241570	Enhancers Weak transcription Active TSS	n/a	n/a	Overlapped CNVs	n/a
10	rs191287121	chr19:43241590-43241591	Enhancers Weak transcription Active TSS	n/a	n/a	Overlapped CNVs	n/a
11	rs559925198	chr19:43241604-43241605	Enhancers Weak transcription Transcr. at gene 5' and 3'	n/a	n/a	Overlapped CNVs	n/a
12	rs529168958	chr19:43241605-43241606	Enhancers Weak transcription Transcr. at gene 5' and 3'	n/a	n/a	Overlapped CNVs	n/a
13	rs550940414	chr19:43241617-43241618	Enhancers Weak transcription Transcr. at gene 5' and 3'	n/a	n/a	Overlapped CNVs	n/a
14	rs549308964	chr19:43241645-43241646	Enhancers Weak transcription Transcr. at gene 5' and 3'	n/a	n/a	Overlapped CNVs	n/a
15	rs569138334	chr19:43241653-43241654	Enhancers Weak transcription Transcr. at gene 5' and 3'	n/a	n/a	Overlapped CNVs	n/a
16	rs531767158	chr19:43241672-43241673	Enhancers Weak transcription Transcr. at gene 5' and 3'	n/a	n/a	Overlapped CNVs	n/a
17	rs551812595	chr19:43241679-43241680	Enhancers Weak transcription Transcr. at gene 5' and 3'	n/a	n/a	Overlapped CNVs	n/a
18	rs375462255	chr19:43241709-43241710	Enhancers Weak transcription Transcr. at gene 5' and 3'	n/a	n/a	Overlapped CNVs	n/a
19	rs185684185	chr19:43241720-43241721	Enhancers Weak transcription Transcr. at gene 5' and 3'	n/a	n/a	Overlapped CNVs	n/a
20	rs550283766	chr19:43241739-43241740	Enhancers Weak transcription Transcr. at gene 5' and 3'	n/a	n/a	Overlapped CNVs	n/a
21	rs569896569	chr19:43241763-43241764	Enhancers Weak transcription Transcr. at gene 5' and 3'	n/a	n/a	Overlapped CNVs	n/a
22	rs567889457	chr19:43241826-43241827	Enhancers Transcr. at gene 5' and 3'	n/a	n/a	Overlapped CNVs	n/a
23	rs568584155	chr19:43241838-43241839	Enhancers Transcr. at gene 5' and 3'	n/a	n/a	Overlapped CNVs	n/a
24	rs190544698	chr19:43241870-43241871	Enhancers Transcr. at gene 5' and 3'	n/a	n/a	Overlapped CNVs	n/a
25	rs181892970	chr19:43241891-43241892	Enhancers Transcr. at gene 5' and 3'	n/a	n/a	Overlapped CNVs	n/a
26	rs538532753	chr19:43241892-43241893	Enhancers Transcr. at gene 5' and 3'	n/a	n/a	Overlapped CNVs	n/a
27	rs576681685	chr19:43241894-43241895	Enhancers Transcr. at gene 5' and 3'	n/a	n/a	Overlapped CNVs	n/a
28	rs147652924	chr19:43241924-43241925	Enhancers Transcr. at gene 5' and 3'	n/a	n/a	Overlapped CNVs	n/a
29	rs557334559	chr19:43241990-43241991	Enhancers Transcr. at gene 5' and 3'	n/a	n/a	Overlapped CNVs	n/a
30	rs535821320	chr19:43241992-43241993	Enhancers Transcr. at gene 5' and 3'	n/a	n/a	Overlapped CNVs	n/a
31	rs375693445	chr19:43241999-43242000	Enhancers Transcr. at gene 5' and 3'	n/a	n/a	Overlapped CNVs	n/a
32	rs185238958	chr19:43242022-43242023	Enhancers Transcr. at gene 5' and 3'	n/a	n/a	Overlapped CNVs	n/a
33	rs142221280	chr19:43242028-43242029	Enhancers Transcr. at gene 5' and 3'	n/a	n/a	Overlapped CNVs	n/a
34	rs547818011	chr19:43242032-43242033	Enhancers Transcr. at gene 5' and 3'	n/a	n/a	Overlapped CNVs	n/a
35	rs559915068	chr19:43242042-43242043	Enhancers Transcr. at gene 5' and 3'	n/a	n/a	Overlapped CNVs	n/a
36	rs145973025	chr19:43242043-43242044	Enhancers Transcr. at gene 5' and 3'	n/a	n/a	Overlapped CNVs	n/a
37	rs147815087	chr19:43242053-43242054	Enhancers Transcr. at gene 5' and 3'	n/a	n/a	Overlapped CNVs	n/a
38	rs562765514	chr19:43242063-43242064	Enhancers Transcr. at gene 5' and 3'	n/a	n/a	Overlapped CNVs	n/a
39	rs534085618	chr19:43242078-43242079	Enhancers Transcr. at gene 5' and 3'	n/a	n/a	Overlapped CNVs	n/a
40	rs531528240	chr19:43242114-43242115	Enhancers Transcr. at gene 5' and 3'	n/a	n/a	Overlapped CNVs	n/a
41	rs551751098	chr19:43242124-43242125	Enhancers Transcr. at gene 5' and 3'	n/a	n/a	Overlapped CNVs	n/a
42	rs141250528	chr19:43242128-43242129	Enhancers Transcr. at gene 5' and 3'	n/a	n/a	Overlapped CNVs	n/a
43	rs116376421	chr19:43242134-43242135	Enhancers Transcr. at gene 5' and 3'	n/a	n/a	Overlapped CNVs	n/a
44	rs189816766	chr19:43242145-43242146	Enhancers Transcr. at gene 5' and 3'	n/a	n/a	Overlapped CNVs	n/a
45	rs118100275	chr19:43242166-43242167	Enhancers Transcr. at gene 5' and 3'	n/a	n/a	Overlapped CNVs	n/a
46	rs550130816	chr19:43242190-43242191	Enhancers Transcr. at gene 5' and 3'	n/a	n/a	Overlapped CNVs	n/a
47	rs558627805	chr19:43242208-43242209	Enhancers Transcr. at gene 5' and 3'	n/a	n/a	Overlapped CNVs	n/a
48	rs71337592	chr19:43242254-43242255	Enhancers Transcr. at gene 5' and 3'	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
49	rs538956396	chr19:43242310-43242311	Enhancers Transcr. at gene 5' and 3'	n/a	n/a	Overlapped CNVs	n/a
50	rs137978284	chr19:43242321-43242322	Enhancers Transcr. at gene 5' and 3'	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:65)

Disease	PMID	Source
Myelodysplastic syndrome	17634407	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Chordoma	21602918	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	21080181	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Cancer	21637783	CNVD
Retinoblastoma	21504564	CNVD
Medulloblastoma	21979893	CNVD
Ovarian cancer	21720365	CNVD
Cancer	20164919	CNVD
Thoracic aortic aneurysm	21092924	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Prostate cancer	18632612	CNVD
Autism	22495311	CNVD
Adenoid cystic carcinoma	18698036	CNVD
Ductal carcinoma	22052326	CNVD
Congenital nephrotic syndrome	18421352	CNVD
Astrocytoma	17934521	CNVD
Leukemia	17361228	CNVD
Adenoid cystic carcinoma	17372589	CNVD
Breast cancer	21858162	CNVD
Breast cancer	17603634	CNVD
Glioma	21971842	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Endometrial cancer	22040021	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	21264507	CNVD
Oligodendroglial tumors	17285580	CNVD
renal disease	20603712	CNVD
Salivary gland adenoid cystic carcinoma	17545515	CNVD
Breast cancer	16608533	CNVD
Neuroblastoma	18923191	CNVD
Breast cancer	21364760	CNVD
Invasive pancreatic ductal carcinoma	18765526	CNVD
Rhabdomyosarcoma	16790082	CNVD
Chordoma	18071362	CNVD
Urothelial carcinoma	21177765	CNVD
small cell lung cancer	20016488	CNVD
Wilms tumour	21544195	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Ovarian neoplasms	16753589	CNVD
Malignant fibrous histiocytomas	21085701	CNVD
Metanephric adenoma	20802469	CNVD
Acute myeloid leukemia	16864856	CNVD
Bladder cancer	21909424	CNVD
Medulloblastoma	16783165	CNVD
Gastric cancer	18160780	CNVD
Hepatocellular carcinoma	16750200	CNVD
Basal cell lymphoma	19029149	CNVD
Breast cancer	20409316	CNVD
Diffuse large b-cell lymphoma	19029149	CNVD
Multiple myeloma	16616336	CNVD
Renal cell carcinoma	18765545	CNVD
Acute myeloid leukemia	20729466	CNVD
Lung cancer	18438408	CNVD
Ovarian clear cell carcinoma	19293255	CNVD
Astrocytoma	22246337	CNVD
Ovarian cancer	22174824	CNVD
Multiple myeloma	17550852	CNVD
Breast cancer	22522925	CNVD
Breast cancer	21509527	CNVD
Cancer	20164920	CNVD
Pancreatic cancer	17952125	CNVD
Ependymoma	20639864	CNVD

Chromatin state (count:539 , 50 per page) page: 1 2 3 4 5 6 7 ... 11

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr19:43238400-43241600	Active TSS	Placenta	Placenta
2	chr19:43239000-43242200	Enhancers	Osteobl	bone
3	chr19:43239000-43242800	Enhancers	Breast Myoepithelial Primary Cells	Breast
4	chr19:43239200-43242000	Enhancers	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
5	chr19:43239400-43242000	Enhancers	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
6	chr19:43239400-43242200	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
7	chr19:43239400-43242400	Enhancers	Foreskin Keratinocyte Primary Cells skin02	Skin
8	chr19:43239400-43242400	Enhancers	HMEC	breast
9	chr19:43239400-43242800	Enhancers	Fetal Adrenal Gland	Adrenal Gland
10	chr19:43239800-43242000	Enhancers	NH-A	brain
11	chr19:43239800-43242600	Enhancers	NHEK	skin
12	chr19:43240000-43242000	Enhancers	Foreskin Keratinocyte Primary Cells skin03	Skin
13	chr19:43240200-43241600	Weak transcription	HSMM	muscle
14	chr19:43240400-43241800	Weak transcription	Foreskin Fibroblast Primary Cells skin02	Skin
15	chr19:43240800-43242200	Enhancers	NHDF-Ad	bronchial
16	chr19:43240800-43242400	Enhancers	IMR90 fetal lung fibroblasts Cell Line	lung
17	chr19:43241000-43242000	Enhancers	NHLF	lung
18	chr19:43241400-43242000	Enhancers	Foreskin Fibroblast Primary Cells skin01	Skin
19	chr19:43241400-43242200	Enhancers	Muscle Satellite Cultured Cells	--
20	chr19:43241600-43242000	Enhancers	HSMM	muscle
21	chr19:43241600-43243400	Transcr. at gene 5' and 3'	Placenta	Placenta
22	chr19:43241800-43242200	Enhancers	Foreskin Fibroblast Primary Cells skin02	Skin
23	chr19:43242800-43243200	Active TSS	Brain Substantia Nigra	brain
24	chr19:43243400-43244600	Active TSS	Placenta	Placenta
25	chr19:43244400-43244600	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
26	chr19:43244600-43245000	Weak transcription	Placenta	Placenta
27	chr19:43244600-43245600	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
28	chr19:43245000-43246400	Enhancers	Placenta	Placenta
29	chr19:43245400-43245600	Bivalent Enhancer	Foreskin Fibroblast Primary Cells skin01	Skin
30	chr19:43245600-43246400	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
31	chr19:43252800-43253200	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
32	chr19:43253000-43253200	Weak transcription	Placenta	Placenta
33	chr19:43253200-43254000	ZNF genes & repeats	iPS DF 19.11 Cell Line	embryonic stem cell
34	chr19:43253200-43254000	Enhancers	Placenta	Placenta
35	chr19:43254000-43261800	Weak transcription	Placenta	Placenta
36	chr19:43261800-43262600	Strong transcription	Placenta	Placenta
37	chr19:43262600-43263200	Enhancers	IMR90 fetal lung fibroblasts Cell Line	lung
38	chr19:43262600-43264200	Weak transcription	Placenta	Placenta
39	chr19:43263200-43264600	Weak transcription	IMR90 fetal lung fibroblasts Cell Line	lung
40	chr19:43263400-43263600	Enhancers	NHLF	lung
41	chr19:43263400-43267600	Enhancers	NHDF-Ad	bronchial
42	chr19:43263600-43264400	Weak transcription	NHLF	lung
43	chr19:43263600-43267600	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
44	chr19:43264200-43264800	Enhancers	Placenta	Placenta
45	chr19:43264200-43265000	Enhancers	Breast Myoepithelial Primary Cells	Breast
46	chr19:43264200-43267200	Enhancers	Osteobl	bone
47	chr19:43264400-43265400	Enhancers	Foreskin Fibroblast Primary Cells skin02	Skin
48	chr19:43264400-43266200	Enhancers	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
49	chr19:43264400-43267600	Enhancers	Muscle Satellite Cultured Cells	--
50	chr19:43264400-43267600	Enhancers	NHLF	lung

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links